← Leaderboards
Julie Hambleton
University Of California San Francisco
$276,489
Attributed
$276,489
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$276,489 · 2
By mechanism
M01$276,489 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- Diane W. Wara$7,985,315
- Mark A Jacobson$6,824,928
- Michael D Prados$7,364,703
- Ann Petru$791,951
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationThromboembolismCardiovascular Disorder PreventionChemopreventionClinical ResearchHuman SubjectHuman Therapy EvaluationClinical Trial Phase IWarfarinVenous ThrombosisCardiovascular Disorder ChemotherapyAnticoagulantsDrug Administration Rate /DurationPatient Oriented Research
Grant awards (9)
Prevention of Recurrent Venous Thromboembolism (PREVENT)$1,825
M01 · FY2004 · RR
Extended low intensity anticoagulation for thromboemboli$68,666
M01 · FY2002 · RR
Prevention of recurrent venous thromboembolism (PREVENT)$68,666
M01 · FY2002 · RR
Extended low intensity anticoagulation for thromboemboli$68,666
M01 · FY2001 · RR
Prevention of recurrent venous thromboembolism (PREVENT)$68,666
M01 · FY2001 · RR
Extended low intensity anticoagulation for thromboemboli$0
M01 · FY2001 · RR
Prevention of recurrent venous thromboembolism (PREVENT)$0
M01 · FY2001 · RR
Prevention of recurrent venous thromboembolism (PREVENT)$0
M01 · FY2000 · RR
Extended low intensity anticoagulation for thromboemboli$0
M01 · FY2000 · RR